Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > Concordia: 13F Filings FOR Q3-2016
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Post by CYBERPUNKon Oct 28, 2016 9:01am
245 Views
Post# 25397279

Concordia: 13F Filings FOR Q3-2016

Concordia: 13F Filings FOR Q3-2016CXRX: 13F Filings for Q3

Montrusco Bolton sold 1,633,122 shares in Q3 (CXRX's largest institutional shareholder in Q1)

You will recall this article from earlier this year:
https://www.newswire.ca/news-releases/montrusco-bolton-investments-not-supporting-concordia-healthcare-corp-compensation-committee-576425791.html

Healthinvest Parters AB sold out 543,000 in Q3

Also Sellers:
Great West Life Assuance Co /CAN / sold 384,774 shares in Q3
Bank of Montreal / CAN sold 214,395 shares in Q3




<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities